The Goldman Sachs Group, Inc. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 4:45 pm Sale | 2023-12-29 | 13G | Atara Biotherapeutics, Inc. ATRA | GOLDMAN SACHS GROUP INC GS | 23,225 0.600% | -221,105 (-90.49%) | Filing |
| 2023-02-06 5:36 pm Purchase | 2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA | GOLDMAN SACHS GROUP INC GS | 244,330 6.400% | 244,330 (New Position) | Filing |